Trial Profile
An Open Study To Estimate The Plasma Pharmacokinetics Of PF-04764793 Administered Via Oral Inhalation Using Dry Powder Inhalers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 May 2011
Price :
$35
*
At a glance
- Drugs PF 4764793 (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- 11 May 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 11 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Mar 2011 Actual initiation date (Jan 2011) added as reported by ClinicalTrials.gov.